SCPH:scPharmaceuticals Inc Snapshot | Charting | News | Options
$4.53 NASDAQ 8:00a ET
April 24 '24 		scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-I... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
     GlobeNewswire
    Full Story →

    Headline News
    scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
    4:01p ET March 13 '24 GlobeNewswire
    scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
    4:01p ET March 6 '24 GlobeNewswire
    scPharmaceuticals to Participate in Two Upcoming Investor Conferences
    4:01p ET February 28 '24 GlobeNewswire
    More News →
    Day  4.14%Week  0.66%Month  9.94%More Charting →
    Today, 1:48p ET Friday April 26 '24. Markets Open.
    Last $4.53
    Day change   4.14%$0.18
    Open $4.38
    Gap at open $0.03
    Previous close $4.35
    Trading volume 75,593
    10 Day avg vol. 158,783
    Shares out. 36.1Mil
    Market cap. $163.3Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 25 '24.

    Historical Price Performance
    3 month   14.85% 
    6 month   14.69% 
    1 year   52.27% 
    2 year   3.41% 

    Earnings
    Previous 12m -$1.42
    Next 12m Estimate -$1.48
    P/E ratio 3.2x
    Revenue 14Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.